{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:56:20Z","timestamp":1790625380344,"version":"4.1.0"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"DOI":"10.1007\/s11095-026-04211-3","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:08:28Z","timestamp":1790622508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering Oral Nanoparticles: Navigating Biological Barriers in the Gastrointestinal Tract"],"prefix":"10.1007","author":[{"given":"Asly","family":"Chua An Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"8","key":"4211_CR1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/ph15080975","volume":"15","author":"M Azman","year":"2022","unstructured":"Azman M, Sabri AH, Anjani QK, Mustaffa MF, Hamid KA. Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery. Pharmaceuticals (Basel). 2022;15(8):975. https:\/\/doi.org\/10.3390\/ph15080975.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"4211_CR2","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3390\/pharmaceutics15122714","volume":"15","author":"K Miyazaki","year":"2023","unstructured":"Miyazaki K, Sasaki A, Mizuuchi H. Advances in the Evaluation of Gastrointestinal Absorption Considering the Mucus Layer. Pharmaceutics. 2023;15(12):2714. https:\/\/doi.org\/10.3390\/pharmaceutics15122714.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4211_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12951-025-03479-8","volume":"23","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang Y, Lu Y, Quan H, Wang Y, Song S, et al. Advanced oral drug delivery systems for gastrointestinal targeted delivery: the design principles and foundations. Journal of Nanobiotechnology. 2025;23(1):400. https:\/\/doi.org\/10.1186\/s12951-025-03479-8.","journal-title":"Journal of Nanobiotechnology"},{"key":"4211_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.compositesb.2022.109826","volume":"236","author":"P Cao","year":"2022","unstructured":"Cao P, Xu ZP, Li L. Tailoring functional nanoparticles for oral vaccine delivery: recent advances and future perspectives. Compos Part B Eng. 2022;236:109826. https:\/\/doi.org\/10.1016\/j.compositesb.2022.109826.","journal-title":"Compos Part B Eng"},{"issue":"3","key":"4211_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/polysaccharides2030038","volume":"2","author":"Y De Anda-Flores","year":"2021","unstructured":"De Anda-Flores Y, Carvajal-Millan E, Campa-Mada A, Lizardi-Mendoza J, Rascon-Chu A, Tanori-Cordova J, et al. Polysaccharide-Based Nanoparticles for Colon-Targeted Drug Delivery Systems. Polysaccharides. 2021;2(3):626\u201347. https:\/\/doi.org\/10.3390\/polysaccharides2030038.","journal-title":"Polysaccharides"},{"key":"4211_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2025.100083","volume-title":"Nano TransMed","author":"UE Ewii","year":"2025","unstructured":"Ewii UE, Attama AA, Olorunsola EO, Onugwu AL, Nwakpa FU, Anyiam C, et al. Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines. In: Nano TransMed, vol. Vol. 4. KeAi Publishing Communications Ltd; 2025. https:\/\/doi.org\/10.1016\/j.ntm.2025.100083."},{"issue":"2","key":"4211_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100043","volume":"1","author":"A Stern","year":"2025","unstructured":"Stern A, Petersen AP, Zierden HC, Duncan GA. The mucosal protein corona in local nanoparticle drug delivery. Cell Biomaterials. 2025;1(2):100043. https:\/\/doi.org\/10.1016\/j.celbio.2025.100043.","journal-title":"Cell Biomaterials"},{"key":"4211_CR8","doi-asserted-by":"publisher","unstructured":"Xi Z, Ahmad E, Zhang W, Li J, Wang A, Faridoon, Wang N, Zhu C, Huang W, Xu L, Yu M, Gan Y. Dual-modified nanoparticles overcome sequential absorption barriers for oral insulin delivery. J Control Release.\u00a02022;342:1\u201313. https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.045","DOI":"10.1016\/j.jconrel.2021.11.045"},{"key":"4211_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","volume":"361","author":"W-C Chou","year":"2023","unstructured":"Chou W-C, Chen Q, Yuan L, Cheng Y-H, He C, Monteiro-Riviere NA, et al. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice. J Control Release. 2023;361:53\u201363. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.040.","journal-title":"J Control Release"},{"key":"4211_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104701","volume":"210","author":"H Noury","year":"2025","unstructured":"Noury H, Rahdar A, Romanholo Ferreira LF, Jamalpoor Z. AI-driven innovations in smart multifunctional nanocarriers for drug and gene delivery: a mini-review. Crit Rev Oncol Hematol. 2025;210:104701. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104701.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4211_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1544393","author":"FD Rodr\u00edguez-G\u00f3mez","year":"2025","unstructured":"Rodr\u00edguez-G\u00f3mez FD, Monferrer D, Penon O, Rivera-Gil P. Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks. Front Med. 2025. https:\/\/doi.org\/10.3389\/fmed.2025.1544393.","journal-title":"Front Med"},{"issue":"5","key":"4211_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/wnan.1338","volume":"7","author":"KM Tyner","year":"2015","unstructured":"Tyner KM, Zou P, Yang X, Zhang H, Cruz CN, Lee SL. Product quality for nanomaterials: current U.S. experience and perspective. WIREs Nanomed Nanobiotechnol. 2015;7(5):640\u201354. https:\/\/doi.org\/10.1002\/wnan.1338.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"4211_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301956","author":"UM Musazzi","year":"2023","unstructured":"Musazzi UM, Franz\u00e8 S, Condorelli F, Minghetti P, Caliceti P. Feeding next\u2010generation nanomedicines to Europe: regulatory and quality challenges. Adv Healthc Mater. 2023. https:\/\/doi.org\/10.1002\/adhm.202301956.","journal-title":"Adv Healthc Mater"},{"key":"4211_CR14","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","volume":"11","author":"CW Pouton","year":"2000","unstructured":"Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems. Eur J Pharm Sci. 2000;11:S93\u20138. https:\/\/doi.org\/10.1016\/S0928-0987(00)00167-6.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"4211_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2217\/nnm.13.68","volume":"8","author":"F Ehmann","year":"2013","unstructured":"Ehmann F, Sakai-Kato K, Duncan R, P\u00e9rez de la Ossa DH, Pita R, Vidal J-M, et al. Next-Generation Nanomedicines and Nanosimilars: EU Regulators\u2019 Initiatives Relating to The Development and Evaluation of Nanomedicines. Nanomedicine. 2013;8(5):849\u201356. https:\/\/doi.org\/10.2217\/nnm.13.68.","journal-title":"Nanomedicine"},{"issue":"3","key":"4211_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrd2197","volume":"6","author":"CJH Porter","year":"2007","unstructured":"Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6(3):231\u201348. https:\/\/doi.org\/10.1038\/nrd2197.","journal-title":"Nat Rev Drug Discov"},{"key":"4211_CR17","doi-asserted-by":"publisher","unstructured":"M\u00fcller R, Junghanns. Nanocrystal technology, drug delivery and clinical applications. Int J of Nanomed. 2008;295. https:\/\/doi.org\/10.2147\/IJN.S595","DOI":"10.2147\/IJN.S595"},{"issue":"10","key":"4211_CR18","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1021\/acsbiomaterials.0c01313","volume":"8","author":"T Kumeria","year":"2022","unstructured":"Kumeria T, Wang J, Kim B, Park JH, Zuidema JM, Klempner M, et al. Enteric polymer-coated porous silicon nanoparticles for site-specific oral delivery of IgA antibody. ACS Biomater Sci Eng. 2022;8(10):4140\u201352. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01313.","journal-title":"ACS Biomater Sci Eng"},{"key":"4211_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2023.102848","volume":"313","author":"H Spleis","year":"2023","unstructured":"Spleis H, Sandmeier M, Claus V, Bernkop-Schn\u00fcrch A. Surface design of nanocarriers: Key to more efficient oral drug delivery systems. Adv Coll Interface Sci. 2023;313:102848. https:\/\/doi.org\/10.1016\/j.cis.2023.102848.","journal-title":"Adv Coll Interface Sci"},{"key":"4211_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijbiomac.2014.08.040","volume":"72","author":"P Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay P, Chakraborty S, Bhattacharya S, Mishra R, Kundu PP. pH-sensitive chitosan\/alginate core-shell nanoparticles for efficient and safe oral insulin delivery. Int J Biol Macromol. 2015;72:640\u20138. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.08.040.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"4211_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/03639045.2025.2536620","volume":"51","author":"AK Philip","year":"2025","unstructured":"Philip AK, Samuel BA, Saleh YS, Mohammad BI, Al-Aubaidy HA. pH-responsive chitosan-alginate hydrogel beads: for enhanced bioavailability and controlled release of omeprazole. Drug Dev Ind Pharm. 2025;51(11):1495\u2013510. https:\/\/doi.org\/10.1080\/03639045.2025.2536620.","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"4211_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/nano11071850","volume":"11","author":"J Schoeller","year":"2021","unstructured":"Schoeller J, Itel F, Wuertz-Kozak K, Gaiser S, Luisier N, Hegemann D, et al. pH-responsive chitosan\/alginate polyelectrolyte complexes on electrospun PLGA nanofibers for controlled drug release. Nanomaterials. 2021;11(7):1850. https:\/\/doi.org\/10.3390\/nano11071850.","journal-title":"Nanomaterials"},{"issue":"8","key":"4211_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081668","volume":"14","author":"SE Alavi","year":"2022","unstructured":"Alavi SE, Bakht U, Koohi Moftakhari Esfahani M, Adelnia H, Abdollahi SH, Ebrahimi Shahmabadi H, et al. A PEGylated nanostructured lipid carrier for enhanced oral delivery of antibiotics. Pharmaceutics. 2022;14(8):1668. https:\/\/doi.org\/10.3390\/pharmaceutics14081668.","journal-title":"Pharmaceutics"},{"key":"4211_CR24","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2024.016","author":"S Mehrdadi","year":"2023","unstructured":"Mehrdadi S. Lipid-based nanoparticles as oral drug delivery systems: overcoming poor gastrointestinal absorption and enhancing bioavailability of peptide\/protein-based drugs. Adv Pharm Bull. 2023. https:\/\/doi.org\/10.34172\/apb.2024.016.","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"4211_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s13346-021-00908-7","volume":"11","author":"M Plaza-Oliver","year":"2021","unstructured":"Plaza-Oliver M, Santander-Ortega MJ, Lozano MV. Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res. 2021;11(2):471\u201397. https:\/\/doi.org\/10.1007\/s13346-021-00908-7.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"4211_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/21691401.2014.951721","volume":"44","author":"SS Hallan","year":"2016","unstructured":"Hallan SS, Kaur P, Kaur V, Mishra N, Vaidya B. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery. Artificial Cells, Nanomedicine, and Biotechnology. 2016;44(1):334\u201349. https:\/\/doi.org\/10.3109\/21691401.2014.951721.","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"issue":"1","key":"4211_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1186\/s12951-025-03753-9","volume":"23","author":"C Oh","year":"2025","unstructured":"Oh C, Hwang J-E, Yim H, Park H, Kim S, Lee JK, et al. pH-responsive Oral liposomal delivery of hydrogen sulfide donor GYY4137 enables colon-targeted therapy for inflammatory bowel disease. Journal of Nanobiotechnology. 2025;23(1):712. https:\/\/doi.org\/10.1186\/s12951-025-03753-9.","journal-title":"Journal of Nanobiotechnology"},{"issue":"10","key":"4211_CR28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/pharmaceutics16101333","volume":"16","author":"S Jacob","year":"2024","unstructured":"Jacob S, Kather FS, Boddu SHS, Shah J, Nair AB. Innovations in nanoemulsion technology: enhancing drug delivery for oral, parenteral, and ophthalmic applications. Pharmaceutics. 2024;16(10):1333. https:\/\/doi.org\/10.3390\/pharmaceutics16101333.","journal-title":"Pharmaceutics"},{"key":"4211_CR29","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.2147\/IJN.S250242","volume":"15","author":"C Jianxian","year":"2020","unstructured":"Jianxian C, Saleem K, Ijaz M, Ur-Rehman M, Murtaza G, Asim MH. Development and in vitro evaluation of gastro-protective aceclofenac-loaded self-emulsifying drug delivery system. Int J Nanomedicine. 2020;15:5217\u201326. https:\/\/doi.org\/10.2147\/IJN.S250242.","journal-title":"Int J Nanomedicine"},{"key":"4211_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lwt.2022.114366","volume":"173","author":"P Chitprasert","year":"2023","unstructured":"Chitprasert P, Dumrongchai T, Rodklongtan A. Effect of in vitro dynamic gastrointestinal digestion on antioxidant activity and bioaccessibility of vitexin nanoencapsulated in vaterite calcium carbonate. LWT. 2023;173:114366. https:\/\/doi.org\/10.1016\/j.lwt.2022.114366.","journal-title":"LWT"},{"key":"4211_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118866","volume":"574","author":"NM Elbaz","year":"2020","unstructured":"Elbaz NM, Owen A, Rannard S, McDonald TO. Controlled synthesis of calcium carbonate nanoparticles and stimuli-responsive multi-layered nanocapsules for oral drug delivery. Int J Pharm. 2020;574:118866. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118866.","journal-title":"Int J Pharm"},{"key":"4211_CR32","doi-asserted-by":"publisher","unstructured":"Taheri S, Volodkin DV, Skirtach AG, Parakhonskiy BV. Calcium carbonate in drug delivery: functional carrier design, applications, and data-driven perspectives. Expert Opin Drug Deliv. 2025;1\u201323. https:\/\/doi.org\/10.1080\/17425247.2025.2587907","DOI":"10.1080\/17425247.2025.2587907"},{"key":"4211_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejpb.2015.01.023","volume":"97","author":"M Abdulkarim","year":"2015","unstructured":"Abdulkarim M, Agull\u00f3 N, Cattoz B, Griffiths P, Bernkop-Schn\u00fcrch A, Borros SG, et al. Nanoparticle diffusion within intestinal mucus: three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles. Eur J Pharm Biopharm. 2015;97:230\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2015.01.023.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"4211_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.apsb.2021.02.020","volume":"11","author":"AL Mart\u00ednez-L\u00f3pez","year":"2021","unstructured":"Mart\u00ednez-L\u00f3pez AL, Gonz\u00e1lez-Navarro CJ, Aranaz P, Vizmanos JL, Irache JM. In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions. Acta Pharm Sin B. 2021;11(4):989\u20131002. https:\/\/doi.org\/10.1016\/j.apsb.2021.02.020.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"4211_CR35","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3390\/pharmaceutics15122708","volume":"15","author":"H Sato","year":"2023","unstructured":"Sato H, Yamada K, Miyake M, Onoue S. Recent advancements in the development of nanocarriers for mucosal drug delivery systems to control oral absorption. Pharmaceutics. 2023;15(12):2708. https:\/\/doi.org\/10.3390\/pharmaceutics15122708.","journal-title":"Pharmaceutics"},{"issue":"8","key":"4211_CR36","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1016\/j.apsb.2023.05.029","volume":"13","author":"C Liu","year":"2023","unstructured":"Liu C, Liu W, Liu Y, Duan H, Chen L, Zhang X, et al. Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel. Acta Pharm Sin B. 2023;13(8):3425\u201343. https:\/\/doi.org\/10.1016\/j.apsb.2023.05.029.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"4211_CR37","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, Su Y-Y, Jiang X-C, Gao J-Q. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system. Drug Deliv Transl Res. 2023;13(3):716\u201337. https:\/\/doi.org\/10.1007\/s13346-022-01252-0.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"4211_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00750-y","volume":"19","author":"JG Song","year":"2021","unstructured":"Song JG, Lee SH, Han H-K. Development of an M cell targeted nanocomposite system for effective oral protein delivery: preparation, in vitro and in vivo characterization. J Nanobiotechnology. 2021;19(1):15. https:\/\/doi.org\/10.1186\/s12951-020-00750-y.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4211_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02724-w","volume":"22","author":"S Tang","year":"2024","unstructured":"Tang S, Wang W, Wang Y, Gao Y, Dai K, Zhang W, et al. Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy. J Nanobiotechnol. 2024;22(1):468. https:\/\/doi.org\/10.1186\/s12951-024-02724-w.","journal-title":"J Nanobiotechnol"},{"issue":"13","key":"4211_CR40","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1021\/acs.analchem.0c01220","volume":"92","author":"X Zhao","year":"2020","unstructured":"Zhao X, Ha W, Gao K, Shi Y. Precisely Traceable Drug Delivery of Azoreductase-Responsive Prodrug for Colon Targeting via Multimodal Imaging. Anal Chem. 2020;92(13):9039\u201347. https:\/\/doi.org\/10.1021\/acs.analchem.0c01220.","journal-title":"Anal Chem"},{"issue":"1","key":"4211_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/molecules27010168","volume":"27","author":"MdK Anwer","year":"2021","unstructured":"Anwer MdK, Ali EA, Iqbal M, Ahmed MM, Aldawsari MF, Saqr AA, et al. Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability. Molecules. 2021;27(1):168. https:\/\/doi.org\/10.3390\/molecules27010168.","journal-title":"Molecules"},{"issue":"6","key":"4211_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/pharmaceutics17060797","volume":"17","author":"AAA Hassan","year":"2025","unstructured":"Hassan AAA, Ramadan E, Krist\u00f3 K, Regdon G, Sov\u00e1ny T. Lipid-polymer hybrid nanoparticles as a smart drug delivery system for peptide\/protein delivery. Pharmaceutics. 2025;17(6):797. https:\/\/doi.org\/10.3390\/pharmaceutics17060797.","journal-title":"Pharmaceutics"},{"key":"4211_CR43","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/IJN.S198353","volume":"14","author":"A Mukherjee","year":"2019","unstructured":"Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomed. 2019;14:1937\u201352. https:\/\/doi.org\/10.2147\/IJN.S198353.","journal-title":"Int J Nanomed"},{"issue":"6","key":"4211_CR44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/pharmaceutics18060744","volume":"18","author":"E Lee","year":"2026","unstructured":"Lee E, Kwon J, Cho H, Woo M, Kim D, Kim J, et al. Polymeric micelle systems for oral drug delivery of small molecule therapeutics. Pharmaceutics. 2026;18(6):744. https:\/\/doi.org\/10.3390\/pharmaceutics18060744.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4211_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10989-025-10801-3","volume":"32","author":"JH Lee","year":"2026","unstructured":"Lee JH, Chun MK, Joo SH, Weon KY. Development of oral self-nanoemulsifying drug delivery system incorporated insulin-hydrophobic ion pairing complex. Int J Pept Res Ther. 2026;32(1):18. https:\/\/doi.org\/10.1007\/s10989-025-10801-3.","journal-title":"Int J Pept Res Ther"},{"key":"4211_CR46","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.2147\/IJN.S512876","volume":"20","author":"T Song","year":"2025","unstructured":"Song T, Wang W, Wu Y, Liu C, Yuan L, Sun Z, et al. Functional liposomes improve the oral absorption of lurasidone hydrochloride by overcoming multiple absorption barriers and eliminating food effect. Int J Nanomedicine. 2025;20:4883\u2013901. https:\/\/doi.org\/10.2147\/IJN.S512876.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"4211_CR47","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1021\/acs.molpharmaceut.2c00895","volume":"20","author":"HT Nguyen","year":"2023","unstructured":"Nguyen HT, Van Duong T, Taylor LS. Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers. Mol Pharm. 2023;20(3):1681\u201395. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00895.","journal-title":"Mol Pharm"},{"issue":"1","key":"4211_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01596-2","volume":"20","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang W, Yu E, Zhuang W, Sun X, Wang H, et al. Preparation of a camptothecin analog FLQY2 self-micelle solid dispersion with improved solubility and bioavailability. J Nanobiotechnol. 2022;20(1):402. https:\/\/doi.org\/10.1186\/s12951-022-01596-2.","journal-title":"J Nanobiotechnol"},{"key":"4211_CR49","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.2147\/IJN.S514455","volume":"20","author":"X Chen","year":"2025","unstructured":"Chen X, Zhou H, Chua An Wen A, Wang S, Zhang L, Yang H, et al. Combined mulberry leaf polysaccharide-caged liposomes for effective oral drug delivery in rat model. Int J Nanomedicine. 2025;20:5377\u201391. https:\/\/doi.org\/10.2147\/IJN.S514455.","journal-title":"Int J Nanomedicine"},{"key":"4211_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2024.134140","volume":"694","author":"ML de Souza","year":"2024","unstructured":"de Souza ML, Sales VdeAW, Sales SGdosS, Sales J\u00fanior PA, Pereira VRA, de Fran\u00e7a EJ, et al. Nanostructured lipid carriers for oral treatment of leishmaniasis: design and preclinical evaluation. Colloids Surf A Physicochem Eng Asp. 2024;694:134140. https:\/\/doi.org\/10.1016\/j.colsurfa.2024.134140.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"7","key":"4211_CR51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41565-020-0693-6","volume":"15","author":"X Han","year":"2020","unstructured":"Han X, Lu Y, Xie J, Zhang E, Zhu H, Du H, et al. Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nat Nanotechnol. 2020;15(7):605\u201314. https:\/\/doi.org\/10.1038\/s41565-020-0693-6.","journal-title":"Nat Nanotechnol"},{"issue":"32","key":"4211_CR52","doi-asserted-by":"publisher","first-page":"13671","DOI":"10.1039\/C5NR03178H","volume":"7","author":"EDH Mansfield","year":"2015","unstructured":"Mansfield EDH, Sillence K, Hole P, Williams AC, Khutoryanskiy VV. POZylation: a new approach to enhance nanoparticle diffusion through mucosal barriers. Nanoscale. 2015;7(32):13671\u20139. https:\/\/doi.org\/10.1039\/C5NR03178H.","journal-title":"Nanoscale"},{"issue":"6","key":"4211_CR53","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.1021\/acsnano.0c02289","volume":"14","author":"Y Zou","year":"2020","unstructured":"Zou Y, Ito S, Yoshino F, Suzuki Y, Zhao L, Komatsu N. Polyglycerol Grafting Shields Nanoparticles from Protein Corona Formation to Avoid Macrophage Uptake. ACS Nano. 2020;14(6):7216\u201326. https:\/\/doi.org\/10.1021\/acsnano.0c02289.","journal-title":"ACS Nano"},{"key":"4211_CR54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","volume":"124","author":"VV Khutoryanskiy","year":"2018","unstructured":"Khutoryanskiy VV. Beyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials. Adv Drug Deliv Rev. 2018;124:140\u20139. https:\/\/doi.org\/10.1016\/j.addr.2017.07.015.","journal-title":"Adv Drug Deliv Rev"},{"key":"4211_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202570001","author":"C Iriarte\u2010Mesa","year":"2025","unstructured":"Iriarte\u2010Mesa C, Bergen J, Danielyan K, Crudo F, Marko D, K\u00e4hlig H, et al. Functionalization of silica nanoparticles for tailored interactions with intestinal cells and chemical modulation of paracellular permeability. Small Sci. 2025. https:\/\/doi.org\/10.1002\/smsc.202570001.","journal-title":"Small Sci"},{"key":"4211_CR56","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.bbrc.2020.11.047","volume":"534","author":"T Ogawa","year":"2021","unstructured":"Ogawa T, Okumura R, Nagano K, Minemura T, Izumi M, Motooka D, et al. Oral intake of silica nanoparticles exacerbates intestinal inflammation. Biochem Biophys Res Commun. 2021;534:540\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.047.","journal-title":"Biochem Biophys Res Commun"},{"key":"4211_CR57","doi-asserted-by":"publisher","DOI":"10.1063\/5.0081267","author":"W Xu","year":"2022","unstructured":"Xu W, Liu X, Liu X. Effects of nanoparticle size and shape in clathrin-mediated endocytosis. J Appl Phys. 2022. https:\/\/doi.org\/10.1063\/5.0081267.","journal-title":"J Appl Phys"},{"issue":"10","key":"4211_CR58","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","volume":"13","author":"N Aibani","year":"2021","unstructured":"Aibani N, Rai R, Patel P, Cuddihy G, Wasan EK. Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery. Pharmaceutics. 2021;13(10):1686. https:\/\/doi.org\/10.3390\/pharmaceutics13101686.","journal-title":"Pharmaceutics"},{"issue":"10","key":"4211_CR59","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1021\/acsptsci.4c00419","volume":"7","author":"L Digiacomo","year":"2024","unstructured":"Digiacomo L, Renzi S, Pirrottina A, Amenitsch H, De Lorenzi V, Pozzi D, et al. PEGylation-dependent cell uptake of lipid nanoparticles revealed by spatiotemporal correlation spectroscopy. ACS Pharmacol Transl Sci. 2024;7(10):3004\u201310. https:\/\/doi.org\/10.1021\/acsptsci.4c00419.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"4211_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007049","author":"EM Pridgen","year":"2013","unstructured":"Pridgen EM, Alexis F, Kuo TT, Levy-Nissenbaum E, Karnik R, Blumberg RS, et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery. Sci Transl Med. 2013. https:\/\/doi.org\/10.1126\/scitranslmed.3007049.","journal-title":"Sci Transl Med"},{"issue":"13","key":"4211_CR61","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3390\/molecules29133131","volume":"29","author":"N Desai","year":"2024","unstructured":"Desai N, Rana D, Salave S, Benival D, Khunt D, Prajapati BG. Achieving endo\/lysosomal escape using smart nanosystems for efficient cellular delivery. Molecules. 2024;29(13):3131. https:\/\/doi.org\/10.3390\/molecules29133131.","journal-title":"Molecules"},{"issue":"11","key":"4211_CR62","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrd4608","volume":"14","author":"NL Trevaskis","year":"2015","unstructured":"Trevaskis NL, Kaminskas LM, Porter CJH. From sewer to saviour \u2014 targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discovery. 2015;14(11):781\u2013803. https:\/\/doi.org\/10.1038\/nrd4608.","journal-title":"Nat Rev Drug Discovery"},{"key":"4211_CR63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2020.07.034","volume":"327","author":"F Deng","year":"2020","unstructured":"Deng F, Bae YH. Bile acid transporter-mediated oral drug delivery. J Control Release. 2020;327:100\u201316. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.034.","journal-title":"J Control Release"},{"key":"4211_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101360","author":"S Cho","year":"2025","unstructured":"Cho S, Rasoulianboroujeni M, Kang RH, Kwon GS. From conventional to next-generation strategies: recent advances in polymeric micelle preparation for drug delivery. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17101360.","journal-title":"Pharmaceutics"},{"issue":"11","key":"4211_CR65","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.3390\/nano11112858","volume":"11","author":"S Razzaq","year":"2021","unstructured":"Razzaq S, Rauf A, Raza A, Akhtar S, Tabish TA, Sandhu MA, et al. A multifunctional polymeric micelle for targeted delivery of paclitaxel by the inhibition of the P-glycoprotein transporters. Nanomaterials. 2021;11(11):2858. https:\/\/doi.org\/10.3390\/nano11112858.","journal-title":"Nanomaterials"},{"key":"4211_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113831","volume":"383","author":"H Sun","year":"2025","unstructured":"Sun H, Zhao J, Liu B, Gou J, He H, Zhang Y, et al. Integrity of polymeric micelles regulates bioavailability of cyclosporine A: a FRET-based analysis during oral delivery. J Control Release. 2025;383:113831. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113831.","journal-title":"J Control Release"},{"key":"4211_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124179","volume":"659","author":"M Ran Woo","year":"2024","unstructured":"Ran Woo M, Bak Y-W, Cheon S, Suk Kim J, Hun Ji S, Park S, et al. Modification of microenvironmental pH of nanoparticles for enhanced solubility and oral bioavailability of poorly water-soluble celecoxib. Int J Pharm. 2024;659:124179. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124179.","journal-title":"Int J Pharm"},{"key":"4211_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s42114-025-01292-3","author":"G Zheng","year":"2025","unstructured":"Zheng G, Zhang B, Yu H, Song Z, Xu X, Zheng Z, et al. Therapeutic applications and potential biological barriers of nano-delivery systems in common gastrointestinal disorders: a comprehensive review. Adv Compos Hybrid Mater. 2025. https:\/\/doi.org\/10.1007\/s42114-025-01292-3.","journal-title":"Adv Compos Hybrid Mater"},{"issue":"4","key":"4211_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26040908","volume":"26","author":"H Amekyeh","year":"2021","unstructured":"Amekyeh H, Billa N. Lyophilized drug-loaded solid lipid nanoparticles formulated with beeswax and theobroma oil. Molecules. 2021;26(4):908. https:\/\/doi.org\/10.3390\/molecules26040908.","journal-title":"Molecules"},{"key":"4211_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejpb.2022.05.003","volume":"176","author":"K Z\u00f6ller","year":"2022","unstructured":"Z\u00f6ller K, To D, Knoll P, Bernkop-Schn\u00fcrch A. Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin. Eur J Pharm Biopharm. 2022;176:32\u201342. https:\/\/doi.org\/10.1016\/j.ejpb.2022.05.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"4211_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtadv.2022.100214","volume":"14","author":"DB Trushina","year":"2022","unstructured":"Trushina DB, Borodina TN, Belyakov S, Antipina MN. Calcium carbonate vaterite particles for drug delivery: Advances and challenges. Materials Today Advances. 2022;14:100214. https:\/\/doi.org\/10.1016\/j.mtadv.2022.100214.","journal-title":"Materials Today Advances"},{"key":"4211_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126377","volume":"687","author":"F Harder","year":"2026","unstructured":"Harder F, Brouwers J, Vanuytsel T, Augustijns P. Assessment of the dynamic nature of upper gastrointestinal pH: a pooled analysis using the fluid aspiration technique. Int J Pharm. 2026;687:126377. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126377.","journal-title":"Int J Pharm"},{"issue":"4","key":"4211_CR73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40262-019-00844-3","volume":"59","author":"D Patel","year":"2020","unstructured":"Patel D, Bertz R, Ren S, Boulton DW, N\u00e5g\u00e5rd M. A systematic review of gastric acid-reducing agent-mediated drug-drug interactions with orally administered medications. Clin Pharmacokinet. 2020;59(4):447\u201362. https:\/\/doi.org\/10.1007\/s40262-019-00844-3.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"4211_CR74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.17510","volume":"58","author":"C Scarpignato","year":"2023","unstructured":"Scarpignato C, Howden CW, Leifke E, Mulford DJ, Lahu G, Facius A, et al. A translational pharmacokinetic\/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection. Aliment Pharmacol Ther. 2023;58(1):16\u201325. https:\/\/doi.org\/10.1111\/apt.17510.","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"4211_CR75","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.3390\/ijms25136818","volume":"25","author":"M Vavallo","year":"2024","unstructured":"Vavallo M, Cingolani S, Cozza G, Schiavone FP, Dottori L, Palumbo C, et al. Autoimmune Gastritis and Hypochlorhydria: Known Concepts from a New Perspective. Int J Mol Sci. 2024;25(13):6818. https:\/\/doi.org\/10.3390\/ijms25136818.","journal-title":"Int J Mol Sci"},{"key":"4211_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120838","volume":"312","author":"H Yuan","year":"2023","unstructured":"Yuan H, Guo C, Liu L, Zhao L, Zhang Y, Yin T, et al. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins\/peptides. Carbohydr Polym. 2023;312:120838. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120838.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"4211_CR77","doi-asserted-by":"publisher","first-page":"8293","DOI":"10.1038\/s41598-024-82130-2","volume":"15","author":"W Nie","year":"2025","unstructured":"Nie W, Zhang X, Kang P, Lan J, Li Z, Gu D, et al. Exploring the influence of polysaccharide on gastrointestinal stability, drug release and formation mechanism of nanoparticles in Zhimu and Huangbai herb pair decoction. Sci Rep. 2025;15(1):8293. https:\/\/doi.org\/10.1038\/s41598-024-82130-2.","journal-title":"Sci Rep"},{"key":"4211_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01283","author":"N Pavlovi\u0107","year":"2018","unstructured":"Pavlovi\u0107 N, Golo\u010dorbin-Kon S, \u00d0ani\u0107 M, Stanimirov B, Al-Salami H, Stankov K, et al. Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.01283.","journal-title":"Front Pharmacol"},{"key":"4211_CR79","doi-asserted-by":"publisher","unstructured":"Bages A, Castelain M, Dietrich N, Raynal R, Ioualalen K. Hydrophobic solid lipid-based microparticles for the protection of gastric-sensitive hydrophilic active biomolecules for oral administration in the treatment of EPI.\u00a0Eur J Pharm Biopharm. 2024;204:114504.\u00a0https:\/\/doi.org\/10.1016\/j.ejpb.2024.114504.","DOI":"10.1016\/j.ejpb.2024.114504"},{"key":"4211_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122069","volume":"625","author":"HM Fadda","year":"2022","unstructured":"Fadda HM, Hellstr\u00f6m PM, Webb D-L. Intra- and inter-subject variability in gastric pH following a low-fat, low-calorie meal. Int J Pharm. 2022;625:122069. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122069.","journal-title":"Int J Pharm"},{"issue":"6","key":"4211_CR81","doi-asserted-by":"publisher","first-page":"b25","DOI":"10.1248\/bpb.b25-00071","volume":"48","author":"H Sato","year":"2025","unstructured":"Sato H. Development of Nanoparticle-Based Mucosal Drug Delivery Systems for Controlling Pharmacokinetic Behaviors. Biol Pharm Bull. 2025;48(6):b25-00071. https:\/\/doi.org\/10.1248\/bpb.b25-00071.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"4211_CR82","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-bioeng-062117-121156","volume":"20","author":"TL Carlson","year":"2018","unstructured":"Carlson TL, Lock JY, Carrier RL. Engineering the mucus barrier. Annu Rev Biomed Eng. 2018;20(1):197\u2013220. https:\/\/doi.org\/10.1146\/annurev-bioeng-062117-121156.","journal-title":"Annu Rev Biomed Eng"},{"issue":"15","key":"4211_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29153482","volume":"29","author":"F Eker","year":"2024","unstructured":"Eker F, Duman H, Akda\u015f\u00e7i E, Bolat E, Sar\u0131ta\u015f S, Karav S, et al. A comprehensive review of nanoparticles: from classification to application and toxicity. Molecules. 2024;29(15):3482. https:\/\/doi.org\/10.3390\/molecules29153482.","journal-title":"Molecules"},{"issue":"9","key":"4211_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16091141","volume":"16","author":"LdeO Macedo","year":"2024","unstructured":"Macedo LdeO, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics. 2024;16(9):1141. https:\/\/doi.org\/10.3390\/pharmaceutics16091141.","journal-title":"Pharmaceutics"},{"issue":"10","key":"4211_CR85","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/ph18101498","volume":"18","author":"NN Porfiryeva","year":"2025","unstructured":"Porfiryeva NN, Zlotver I, Sosnik A. Combined effect of size and charge on the interaction of nanoparticles with mucus-mimicking mucin hydrogels. Pharmaceuticals (Basel). 2025;18(10):1498. https:\/\/doi.org\/10.3390\/ph18101498.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4211_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202304713","author":"F Veider","year":"2024","unstructured":"Veider F, Armengol ES, Bernkop\u2010Schn\u00fcrch A. Charge\u2010reversible nanoparticles: advanced delivery systems for therapy and diagnosis. Small. 2024. https:\/\/doi.org\/10.1002\/smll.202304713.","journal-title":"Small"},{"key":"4211_CR87","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jcis.2022.06.126","volume":"626","author":"TMM Ways","year":"2022","unstructured":"Ways TMM, Filippov SK, Maji S, Glassner M, Ceg\u0142owski M, Hoogenboom R, et al. Mucus-penetrating nanoparticles based on chitosan grafted with various non-ionic polymers: Synthesis, structural characterisation and diffusion studies. J Colloid Interface Sci. 2022;626:251\u201364. https:\/\/doi.org\/10.1016\/j.jcis.2022.06.126.","journal-title":"J Colloid Interface Sci"},{"issue":"3","key":"4211_CR88","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1021\/acsnano.2c11147","volume":"17","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ma Y, Chen X, Li M, Ma X, Cheng G, et al. Mucus penetration of surface-engineered nanoparticles in various pH microenvironments. ACS Nano. 2023;17(3):2813\u201328. https:\/\/doi.org\/10.1021\/acsnano.2c11147.","journal-title":"ACS Nano"},{"issue":"24","key":"4211_CR89","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/d1nr02065j","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi L, Zhang J, Zhao M, Tang S, Cheng X, Zhang W, et al. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021;13(24):10748\u201364. https:\/\/doi.org\/10.1039\/d1nr02065j.","journal-title":"Nanoscale"},{"issue":"39","key":"4211_CR90","doi-asserted-by":"publisher","first-page":"27026","DOI":"10.1021\/acsnano.4c09838","volume":"18","author":"D Yuan","year":"2024","unstructured":"Yuan D, Niu Z, Zheng W, Zhao Q, Zhou F, Zhao M. Mind the particle rigidity: blooms the bioavailability via rapidly crossing the mucus layer and alters the intracellular fate of curcumin. ACS Nano. 2024;18(39):27026\u201341. https:\/\/doi.org\/10.1021\/acsnano.4c09838.","journal-title":"ACS Nano"},{"issue":"4","key":"4211_CR91","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1021\/acsmacrolett.2c00639","volume":"12","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li S, Loch K, Duncan GA, Kaler L, Pangeni R, et al. pH-Responsive Mucus-Penetrating Nanoparticles for Enhanced Cellular Internalization by Local Administration in Vaginal Tissue. ACS Macro Lett. 2023;12(4):446\u201353. https:\/\/doi.org\/10.1021\/acsmacrolett.2c00639.","journal-title":"ACS Macro Lett"},{"key":"4211_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.132107","volume":"428","author":"S Hu","year":"2022","unstructured":"Hu S, Yang Z, Wang S, Wang L, He Q, Tang H, et al. Zwitterionic polydopamine modified nanoparticles as an efficient nanoplatform to overcome both the mucus and epithelial barriers. Chem Eng J. 2022;428:132107. https:\/\/doi.org\/10.1016\/j.cej.2021.132107.","journal-title":"Chem Eng J"},{"issue":"49","key":"4211_CR93","doi-asserted-by":"publisher","first-page":"16963","DOI":"10.1021\/acs.nanolett.5c02487","volume":"25","author":"CA Stevens","year":"2025","unstructured":"Stevens CA, Sevarika B, Wilson BK, Wang C-M, C\u00e1rcamo-Oyarce G, Romeo J, et al. Polymer blend controls nanoparticles\u2019 surface charge for improved mucus penetration and epithelial cell adhesion. Nano Lett. 2025;25(49):16963\u20139. https:\/\/doi.org\/10.1021\/acs.nanolett.5c02487.","journal-title":"Nano Lett"},{"issue":"1","key":"4211_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05061-3","volume":"9","author":"M Yu","year":"2018","unstructured":"Yu M, Xu L, Tian F, Su Q, Zheng N, Yang Y, et al. Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers. Nat Commun. 2018;9(1):2607. https:\/\/doi.org\/10.1038\/s41467-018-05061-3.","journal-title":"Nat Commun"},{"key":"4211_CR95","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jmps.2017.12.014","volume":"112","author":"J Wang","year":"2018","unstructured":"Wang J, Yang Y, Yu M, Hu G, Gan Y, Gao H, et al. Diffusion of rod-like nanoparticles in non-adhesive and adhesive porous polymeric gels. J Mech Phys Solids. 2018;112:431\u201357. https:\/\/doi.org\/10.1016\/j.jmps.2017.12.014.","journal-title":"J Mech Phys Solids"},{"key":"4211_CR96","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfb.2015.07.038","volume":"135","author":"BH Bajka","year":"2015","unstructured":"Bajka BH, Rigby NM, Cross KL, Macierzanka A, Mackie AR. The influence of small intestinal mucus structure on particle transport ex vivo. Colloids Surf, B. 2015;135:73\u201380. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.07.038.","journal-title":"Colloids Surf, B"},{"issue":"2","key":"4211_CR97","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ibd\/izaf293","volume":"32","author":"W Arras","year":"2026","unstructured":"Arras W, Oosterlinck B, Gassman J, De Man JG, Jauregui-Amezaga A, De Winter BY, et al. Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications. Inflamm Bowel Dis. 2026;32(2):375\u201389. https:\/\/doi.org\/10.1093\/ibd\/izaf293.","journal-title":"Inflamm Bowel Dis"},{"key":"4211_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104567","volume":"91","author":"M Lo Conte","year":"2023","unstructured":"Lo Conte M, Cosorich I, Ferrarese R, Antonini Cencicchio M, Nobili A, Palmieri V, et al. Alterations of the intestinal mucus layer correlate with dysbiosis and immune dysregulation in human Type 1 Diabetes. EBioMedicine. 2023;91:104567. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104567.","journal-title":"EBioMedicine"},{"issue":"1","key":"4211_CR99","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12951-022-01539-x","volume":"20","author":"DA Subramanian","year":"2022","unstructured":"Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnol. 2022;20(1):362. https:\/\/doi.org\/10.1186\/s12951-022-01539-x.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"4211_CR100","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1039\/D4LC00774C","volume":"25","author":"C-M Wang","year":"2025","unstructured":"Wang C-M, Oberoi HS, Law D, Li Y, Kassis T, Griffith LG, et al. Human mesofluidic intestinal model for studying transport of drug carriers and bacteria through a live mucosal barrier. Lab Chip. 2025;25(12):2990\u20133004. https:\/\/doi.org\/10.1039\/D4LC00774C.","journal-title":"Lab Chip"},{"key":"4211_CR101","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejpb.2015.01.008","volume":"97","author":"I Pereira de Sousa","year":"2015","unstructured":"Pereira de Sousa I, Cattoz B, Wilcox MD, Griffiths PC, Dalgliesh R, Rogers S, et al. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. Eur J Pharm Biopharm. 2015;97:257\u201364. https:\/\/doi.org\/10.1016\/j.ejpb.2015.01.008.","journal-title":"Eur J Pharm Biopharm"},{"issue":"04","key":"4211_CR102","doi-asserted-by":"publisher","DOI":"10.1142\/S179398441441013X","volume":"04","author":"E Samaridou","year":"2014","unstructured":"Samaridou E, Karidi K, de Sousa IP, Cattoz B, Griffiths P, Kammona O, et al. Enzyme-functionalized PLGA nanoparticles with enhanced mucus permeation rate. Nano LIFE. 2014;04(04):1441013. https:\/\/doi.org\/10.1142\/S179398441441013X.","journal-title":"Nano LIFE"},{"key":"4211_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114966","volume":"200","author":"C-M Wang","year":"2023","unstructured":"Wang C-M, Fernez MT, Woolston BM, Carrier RL. Native gastrointestinal mucus: Critical features and techniques for studying interactions with drugs, drug carriers, and bacteria. Adv Drug Deliv Rev. 2023;200:114966. https:\/\/doi.org\/10.1016\/j.addr.2023.114966.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4211_CR104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13099-023-00540-5","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, Wen Q, Qin Y, Xia Q, Shen C, Song S. Gut microbiota and host cytochrome P450 characteristics in the pseudo germ-free model: co-contributors to a diverse metabolic landscape. Gut Pathog. 2023;15(1):15. https:\/\/doi.org\/10.1186\/s13099-023-00540-5.","journal-title":"Gut Pathog"},{"issue":"24","key":"4211_CR105","doi-asserted-by":"publisher","first-page":"16488","DOI":"10.1039\/D3RA00866E","volume":"13","author":"T Wang","year":"2023","unstructured":"Wang T, Wu C, Hu Y, Zhang Y, Ma J. Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review. RSC Adv. 2023;13(24):16488\u2013511. https:\/\/doi.org\/10.1039\/D3RA00866E.","journal-title":"RSC Adv"},{"issue":"5","key":"4211_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050687","volume":"13","author":"A Romeo","year":"2021","unstructured":"Romeo A, Musumeci T, Carbone C, Bonaccorso A, Corvo S, Lupo G, et al. Ferulic acid-loaded polymeric nanoparticles for potential ocular delivery. Pharmaceutics. 2021;13(5):687. https:\/\/doi.org\/10.3390\/pharmaceutics13050687.","journal-title":"Pharmaceutics"},{"key":"4211_CR107","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. https:\/\/doi.org\/10.1016\/j.addr.2016.06.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"4211_CR108","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2016.1176822","volume":"4","author":"F McCartney","year":"2016","unstructured":"McCartney F, Gleeson JP, Brayden DJ. Safety concerns over the use of intestinal permeation enhancers: A mini-review. Tissue Barriers. 2016;4(2):e1176822. https:\/\/doi.org\/10.1080\/21688370.2016.1176822.","journal-title":"Tissue Barriers"},{"key":"4211_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10342","author":"KC Fein","year":"2023","unstructured":"Fein KC, Gleeson JP, Cochran K, Lamson NG, Doerfler R, Melamed JR, et al. Long\u2010term daily oral administration of intestinal permeation enhancers is safe and effective in mice. Bioeng Transl Med. 2023. https:\/\/doi.org\/10.1002\/btm2.10342.","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"4211_CR110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/pharmaceutics18010055","volume":"18","author":"A Ribeiro","year":"2025","unstructured":"Ribeiro A, Nunes R. Selective nanoparticulate systems for drug delivery in inflammatory bowel disease. Pharmaceutics. 2025;18(1):55. https:\/\/doi.org\/10.3390\/pharmaceutics18010055.","journal-title":"Pharmaceutics"},{"issue":"5","key":"4211_CR111","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s11154-022-09735-8","volume":"23","author":"VR Aroda","year":"2022","unstructured":"Aroda VR, Blonde L, Pratley RE. A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Rev Endocr Metab Disord. 2022;23(5):979\u201394. https:\/\/doi.org\/10.1007\/s11154-022-09735-8.","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"4211_CR112","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/mp200572t","volume":"9","author":"K Sonaje","year":"2012","unstructured":"Sonaje K, Chuang E-Y, Lin K-J, Yen T-C, Su F-Y, Tseng MT, et al. Opening of Epithelial Tight Junctions and Enhancement of Paracellular Permeation by Chitosan: Microscopic, Ultrastructural, and Computed-Tomographic Observations. Mol Pharm. 2012;9(5):1271\u20139. https:\/\/doi.org\/10.1021\/mp200572t.","journal-title":"Mol Pharm"},{"issue":"9","key":"4211_CR113","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.apsb.2024.06.015","volume":"14","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Luo S, Xu M, He Q, Xie J, Wu J, et al. Transepithelial transport of nanoparticles in oral drug delivery: from the perspective of surface and holistic property modulation. Acta Pharm Sin B. 2024;14(9):3876\u2013900. https:\/\/doi.org\/10.1016\/j.apsb.2024.06.015.","journal-title":"Acta Pharm Sin B"},{"issue":"13","key":"4211_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137098","volume":"25","author":"ME Hansen","year":"2024","unstructured":"Hansen ME, Ibrahim Y, Desai TA, Koval M. Nanostructure-mediated transport of therapeutics through epithelial barriers. Int J Mol Sci. 2024;25(13):7098. https:\/\/doi.org\/10.3390\/ijms25137098.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4211_CR115","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1007\/s10620-023-08122-w","volume":"68","author":"KA Dunleavy","year":"2023","unstructured":"Dunleavy KA, Raffals LE, Camilleri M. Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics. Dig Dis Sci. 2023;68(12):4306\u201320. https:\/\/doi.org\/10.1007\/s10620-023-08122-w.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"4211_CR116","doi-asserted-by":"publisher","first-page":"15627","DOI":"10.1021\/acsnano.2c05317","volume":"16","author":"J Wu","year":"2022","unstructured":"Wu J, Zhu Z, Liu W, Zhang Y, Kang Y, Liu J, et al. How nanoparticles open the paracellular route of biological barriers: mechanisms, applications, and prospects. ACS Nano. 2022;16(10):15627\u201352. https:\/\/doi.org\/10.1021\/acsnano.2c05317.","journal-title":"ACS Nano"},{"key":"4211_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm4677","author":"J-J Zou","year":"2022","unstructured":"Zou J-J, Wei G, Xiong C, Yu Y, Li S, Hu L, et al. Efficient oral insulin delivery enabled by transferrin-coated acid-resistant metal-organic framework nanoparticles. Sci Adv. 2022. https:\/\/doi.org\/10.1126\/sciadv.abm4677.","journal-title":"Sci Adv"},{"key":"4211_CR118","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.addr.2020.07.026","volume":"157","author":"Y Ju","year":"2020","unstructured":"Ju Y, Guo H, Edman M, Hamm-Alvarez SF. Application of advances in endocytosis and membrane trafficking to drug delivery. Adv Drug Deliv Rev. 2020;157:118\u201341. https:\/\/doi.org\/10.1016\/j.addr.2020.07.026.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"4211_CR119","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s40259-021-00500-y","volume":"35","author":"ALJ Marschall","year":"2021","unstructured":"Marschall ALJ. Targeting the inside of cells with biologicals: chemicals as a delivery strategy. BioDrugs. 2021;35(6):643\u201371. https:\/\/doi.org\/10.1007\/s40259-021-00500-y.","journal-title":"BioDrugs"},{"issue":"8","key":"4211_CR120","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/iub.485","volume":"63","author":"Z Wang","year":"2011","unstructured":"Wang Z, Tiruppathi C, Cho J, Minshall RD, Malik AB. Delivery of nanoparticle\u2010complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life. 2011;63(8):659\u201367. https:\/\/doi.org\/10.1002\/iub.485.","journal-title":"IUBMB Life"},{"issue":"1","key":"4211_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02930-6","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Mo Y, Sun Y, Li J, An Y, Feng N, et al. Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties. J Nanobiotechnol. 2024;22(1):669. https:\/\/doi.org\/10.1186\/s12951-024-02930-6.","journal-title":"J Nanobiotechnol"},{"key":"4211_CR122","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jconrel.2023.06.021","volume":"360","author":"BD Tri","year":"2023","unstructured":"Tri BD, Shashni B, Matsui H, Nagasaki Y. Designing poly(gamma-aminobutyric acid)-based nanoparticles for the treatment of major depressive disorders. J Control Release. 2023;360:110\u201321. https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.021.","journal-title":"J Control Release"},{"issue":"17","key":"4211_CR123","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1039\/D2NA00222A","volume":"4","author":"Y Yang","year":"2022","unstructured":"Yang Y, Sun W. Recent advances in redox-responsive nanoparticles for combined cancer therapy. Nanoscale Adv. 2022;4(17):3504\u201316. https:\/\/doi.org\/10.1039\/D2NA00222A.","journal-title":"Nanoscale Adv"},{"issue":"12","key":"4211_CR124","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1021\/mp500439c","volume":"11","author":"AM Bannunah","year":"2014","unstructured":"Bannunah AM, Vllasaliu D, Lord J, Stolnik S. Mechanisms of Nanoparticle Internalization and Transport Across an Intestinal Epithelial Cell Model: Effect of Size and Surface Charge. Mol Pharm. 2014;11(12):4363\u201373. https:\/\/doi.org\/10.1021\/mp500439c.","journal-title":"Mol Pharm"},{"key":"4211_CR125","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jconrel.2022.05.021","volume":"347","author":"T Briot","year":"2022","unstructured":"Briot T, Kolenda C, Ferry T, Medina M, Laurent F, Leboucher G, et al. Paving the way for phage therapy using novel drug delivery approaches. J Control Release. 2022;347:414\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.021.","journal-title":"J Control Release"},{"issue":"1","key":"4211_CR126","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12951-021-00770-2","volume":"19","author":"S Guo","year":"2021","unstructured":"Guo S, Liang Y, Liu L, Yin M, Wang A, Sun K, et al. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics. Journal of Nanobiotechnology. 2021;19(1):32. https:\/\/doi.org\/10.1186\/s12951-021-00770-2.","journal-title":"Journal of Nanobiotechnology"},{"key":"4211_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102585","volume":"64","author":"P Pandya","year":"2021","unstructured":"Pandya P, Giram P, Bhole RP, Chang H-I, Raut SY. Nanocarriers based oral lymphatic drug targeting: Strategic bioavailability enhancement approaches. Journal of Drug Delivery Science and Technology. 2021;64:102585. https:\/\/doi.org\/10.1016\/j.jddst.2021.102585.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"8","key":"4211_CR128","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Lu Y, Qi J, Wu W. An update on oral drug delivery via intestinal lymphatic transport. Acta Pharmaceutica Sinica B. 2021;11(8):2449\u201368. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.022.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"4211_CR129","doi-asserted-by":"publisher","unstructured":"Fang JY, Chen CH, Chang CC, Shih TH, Aljuffali IA, Yeh TS. Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgery. Int J Nanomedicine. 2015;2403. https:\/\/doi.org\/10.2147\/IJN.S79522.","DOI":"10.2147\/IJN.S79522"},{"issue":"5","key":"4211_CR130","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s11095-014-1579-9","volume":"32","author":"S Han","year":"2015","unstructured":"Han S, Hu L, Quach T, Simpson JS, Trevaskis NL, Porter CJH. Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug. Pharm Res. 2015;32(5):1830\u201344. https:\/\/doi.org\/10.1007\/s11095-014-1579-9.","journal-title":"Pharm Res"},{"issue":"9","key":"4211_CR131","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s11095-014-1321-7","volume":"31","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Jiang S, Liu Z, Niu B, Gu W, Li Y, et al. Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation. Pharm Res. 2014;31(9):2266\u201375. https:\/\/doi.org\/10.1007\/s11095-014-1321-7.","journal-title":"Pharm Res"},{"key":"4211_CR132","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biomaterials.2018.10.012","volume":"188","author":"Y Mao","year":"2019","unstructured":"Mao Y, Feng S, Li S, Zhao Q, Di D, Liu Y, et al. Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs. Biomaterials. 2019;188:173\u201386. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.10.012.","journal-title":"Biomaterials"},{"issue":"2\u20133","key":"4211_CR133","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jconrel.2005.08.013","volume":"108","author":"Y Mo","year":"2005","unstructured":"Mo Y, Lim L-Y. Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Control Release. 2005;108(2\u20133):244\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2005.08.013.","journal-title":"J Control Release"},{"key":"4211_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119201","volume":"580","author":"D Izgelov","year":"2020","unstructured":"Izgelov D, Shmoeli E, Domb AJ, Hoffman A. The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats. Int J Pharm. 2020;580:119201. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119201.","journal-title":"Int J Pharm"},{"issue":"23","key":"4211_CR135","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1111\/bph.15644","volume":"178","author":"P Ry\u0161\u00e1nek","year":"2021","unstructured":"Ry\u0161\u00e1nek P, Grus T, Luk\u00e1\u010d P, Kozl\u00edk P, K\u0159\u00ed\u017eek T, Pozniak J, et al. Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs. Br J Pharmacol. 2021;178(23):4663\u201374. https:\/\/doi.org\/10.1111\/bph.15644.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"4211_CR136","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3390\/pharmaceutics15112532","volume":"15","author":"M Yousef","year":"2023","unstructured":"Yousef M, Park C, Henostroza M, Bou Chacra N, Davies NM, L\u00f6benberg R. Development of a Novel In Vitro Model to Study Lymphatic Uptake of Drugs via Artificial Chylomicrons. Pharmaceutics. 2023;15(11):2532. https:\/\/doi.org\/10.3390\/pharmaceutics15112532.","journal-title":"Pharmaceutics"},{"key":"4211_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1400739","author":"D Del Castillo","year":"2024","unstructured":"Del Castillo D, Lo DD. Deciphering the M-cell niche: insights from mouse models on how microfold cells \u201cknow\u201d where they are needed. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1400739.","journal-title":"Front Immunol"},{"key":"4211_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-016-0083-1","author":"H Ahn","year":"2016","unstructured":"Ahn H, Park J-H. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016. https:\/\/doi.org\/10.1186\/s40824-016-0083-1.","journal-title":"Biomater Res"},{"issue":"4","key":"4211_CR139","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/liquids3040029","volume":"3","author":"L Dinh","year":"2023","unstructured":"Dinh L, Yan B. Oral drug delivery via intestinal lymphatic transport utilizing lipid-based lyotropic liquid crystals. Liquids. 2023;3(4):456\u201368. https:\/\/doi.org\/10.3390\/liquids3040029.","journal-title":"Liquids"},{"issue":"2","key":"4211_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020267","volume":"13","author":"A Obinu","year":"2021","unstructured":"Obinu A, Burrai GP, Cavalli R, Galleri G, Migheli R, Antuofermo E, et al. Transmucosal solid lipid nanoparticles to improve genistein absorption via intestinal lymphatic transport. Pharmaceutics. 2021;13(2):267. https:\/\/doi.org\/10.3390\/pharmaceutics13020267.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4211_CR141","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s40168-023-01578-y","volume":"11","author":"AL Degraeve","year":"2023","unstructured":"Degraeve AL, Haufroid V, Loriot A, Gatto L, Andries V, Vereecke L, et al. Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome. 2023;11(1):138. https:\/\/doi.org\/10.1186\/s40168-023-01578-y.","journal-title":"Microbiome"},{"key":"4211_CR142","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101986R","author":"IJ Dikeocha","year":"2022","unstructured":"Dikeocha IJ, Al\u2010Kabsi AM, Miftahussurur M, Alshawsh MA. Pharmacomicrobiomics: influence of gut microbiota on drug and xenobiotic metabolism. FASEB J. 2022. https:\/\/doi.org\/10.1096\/fj.202101986R.","journal-title":"FASEB J"},{"issue":"6143","key":"4211_CR143","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1235872","volume":"341","author":"HJ Haiser","year":"2013","unstructured":"Haiser HJ, Gootenberg DB, Chatman K, Sirasani G, Balskus EP, Turnbaugh PJ. Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta. Science. 2013;341(6143):295\u20138. https:\/\/doi.org\/10.1126\/science.1235872.","journal-title":"Science"},{"key":"4211_CR144","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33953","author":"N Koppel","year":"2018","unstructured":"Koppel N, Bisanz JE, Pandelia M-E, Turnbaugh PJ, Balskus EP. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. Elife. 2018. https:\/\/doi.org\/10.7554\/eLife.33953.","journal-title":"Elife"},{"key":"4211_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114021","volume":"179","author":"Y Lee","year":"2021","unstructured":"Lee Y, Kamada N, Moon JJ. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome. Adv Drug Deliv Rev. 2021;179:114021. https:\/\/doi.org\/10.1016\/j.addr.2021.114021.","journal-title":"Adv Drug Deliv Rev"},{"key":"4211_CR146","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00072-19","author":"F Zhang","year":"2020","unstructured":"Zhang F, He F, Li L, Guo L, Zhang B, Yu S, et al. Bioavailability based on the gut microbiota: a new perspective. Microbiol Mol Biol Rev. 2020. https:\/\/doi.org\/10.1128\/MMBR.00072-19.","journal-title":"Microbiol Mol Biol Rev"},{"key":"4211_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119605","volume":"586","author":"M Abid","year":"2020","unstructured":"Abid M, Naveed M, Azeem I, Faisal A, Faizan Nazar M, Yameen B. Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil. Int J Pharm. 2020;586:119605. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119605.","journal-title":"Int J Pharm"},{"key":"4211_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202401408","author":"L Cao","year":"2026","unstructured":"Cao L, Peng J, Duan D, Cai H, Cao Q, Zhang W, et al. Colon enzyme\u2010activated prebiotic nanomedicine for targeted therapy of inflammatory bowel disease. Small Methods. 2026. https:\/\/doi.org\/10.1002\/smtd.202401408.","journal-title":"Small Methods"},{"issue":"10","key":"4211_CR149","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.addr.2011.05.019","volume":"63","author":"JA Y\u00e1\u00f1ez","year":"2011","unstructured":"Y\u00e1\u00f1ez JA, Wang SWJ, Knemeyer IW, Wirth MA, Alton KB. Intestinal lymphatic transport for drug delivery. Advanced Drug Delivery Reviews, Lymphatic Drug Delivery: Therapy, Imaging and Nanotechnology. 2011;63(10):923\u201342. https:\/\/doi.org\/10.1016\/j.addr.2011.05.019.","journal-title":"Advanced Drug Delivery Reviews, Lymphatic Drug Delivery: Therapy, Imaging and Nanotechnology"},{"key":"4211_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102758","volume":"37","author":"J Xu","year":"2026","unstructured":"Xu J, Tang P, Sun X, Song Y, Lin K, Jiang S, et al. Targeting IBD treatment: smart drug delivery systems for oral administration. Mater Today Bio. 2026;37:102758. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102758.","journal-title":"Mater Today Bio"},{"key":"4211_CR151","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2013.10.022","volume":"173","author":"BE Benediktsd\u00f3ttir","year":"2014","unstructured":"Benediktsd\u00f3ttir BE, Baldursson \u00d3, M\u00e1sson M. Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application. J Control Release. 2014;173:18\u201331. https:\/\/doi.org\/10.1016\/j.jconrel.2013.10.022.","journal-title":"J Control Release"},{"issue":"1","key":"4211_CR152","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/acs.biomac.0c00663","volume":"22","author":"C Federer","year":"2021","unstructured":"Federer C, Kurpiers M, Bernkop-Schn\u00fcrch A. Thiolated chitosans: a multi-talented class of polymers for various applications. Biomacromol. 2021;22(1):24\u201356. https:\/\/doi.org\/10.1021\/acs.biomac.0c00663.","journal-title":"Biomacromol"},{"key":"4211_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126373","volume":"687","author":"H Al-Lawati","year":"2026","unstructured":"Al-Lawati H, Binkhathlan Z. Polymeric micelles for oral drug delivery: progress and innovations in preclinical studies. Int J Pharm. 2026;687:126373. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126373.","journal-title":"Int J Pharm"},{"issue":"7","key":"4211_CR154","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/pharmaceutics13071103","volume":"13","author":"T-T-L Nguyen","year":"2021","unstructured":"Nguyen T-T-L, Duong V-A, Maeng H-J. Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability. Pharmaceutics. 2021;13(7):1103. https:\/\/doi.org\/10.3390\/pharmaceutics13071103.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4211_CR155","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12951-026-04067-0","volume":"24","author":"H Sun","year":"2026","unstructured":"Sun H, Gou J, Bi X, Song J, Liu B, Jin X, et al. OCTN2-targeted and ROS-responsive hybrid polymeric micelles for oral delivery of docetaxel. Journal of Nanobiotechnology. 2026;24(1):182. https:\/\/doi.org\/10.1186\/s12951-026-04067-0.","journal-title":"Journal of Nanobiotechnology"},{"key":"4211_CR156","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cant\u00f9 L, et al. Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.031.","journal-title":"J Control Release"},{"issue":"8","key":"4211_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/polym15081974","volume":"15","author":"MS Hussain","year":"2023","unstructured":"Hussain MS, Faisal KS, Clulow AJ, Albrecht H, Krasowska M, Blencowe A. Influence of lyophilization and cryoprotection on the stability and morphology of drug-loaded poly(ethylene glycol-b-\u03b5-caprolactone) micelles. Polymers (Basel). 2023;15(8):1974. https:\/\/doi.org\/10.3390\/polym15081974.","journal-title":"Polymers (Basel)"},{"issue":"2","key":"4211_CR158","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/jbm.a.31504","volume":"85A","author":"ZL Yang","year":"2008","unstructured":"Yang ZL, Li XR, Yang KW, Liu Y. Amphotericin B\u2010loaded poly(ethylene glycol)\u2013poly(lactide) micelles: preparation, freeze\u2010drying, and in vitro release. J Biomed Mater Res A. 2008;85A(2):539\u201346. https:\/\/doi.org\/10.1002\/jbm.a.31504.","journal-title":"J Biomed Mater Res A"},{"key":"4211_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118586","volume":"569","author":"X Hou","year":"2019","unstructured":"Hou X, Cao B, He Y, Guo T, Li Z, Liu Y, et al. Improved self-assembled micelles based on supercritical fluid technology as a novel oral delivery system for enhancing germacrone oral bioavailability. Int J Pharm. 2019;569:118586. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118586.","journal-title":"Int J Pharm"},{"key":"4211_CR160","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejpb.2021.07.005","volume":"167","author":"A Almeida","year":"2021","unstructured":"Almeida A, Linares V, Mora-Casta\u00f1o G, Casas M, Caraballo I, Sarmento B. 3D printed systems for colon-specific delivery of camptothecin-loaded chitosan micelles. Eur J Pharm Biopharm. 2021;167:48\u201356. https:\/\/doi.org\/10.1016\/j.ejpb.2021.07.005.","journal-title":"Eur J Pharm Biopharm"},{"key":"4211_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119105","volume":"578","author":"T Chen","year":"2020","unstructured":"Chen T, Tu L, Wang G, Qi N, Wu W, Zhang W, et al. Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy. Int J Pharm. 2020;578:119105. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119105.","journal-title":"Int J Pharm"},{"issue":"14","key":"4211_CR162","doi-asserted-by":"publisher","first-page":"13044","DOI":"10.1021\/acsnano.3c02403","volume":"17","author":"SA Ejazi","year":"2023","unstructured":"Ejazi SA, Louisthelmy R, Maisel K. Mechanisms of nanoparticle transport across intestinal tissue: an oral delivery perspective. ACS Nano. 2023;17(14):13044\u201361. https:\/\/doi.org\/10.1021\/acsnano.3c02403.","journal-title":"ACS Nano"},{"issue":"16","key":"4211_CR163","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1021\/acs.nanolett.3c02128","volume":"23","author":"Y Ma","year":"2023","unstructured":"Ma Y, Guo Y, Liu S, Hu Y, Yang C, Cheng G, et al. pH-mediated mucus penetration of zwitterionic polydopamine-modified silica nanoparticles. Nano Lett. 2023;23(16):7552\u201360. https:\/\/doi.org\/10.1021\/acs.nanolett.3c02128.","journal-title":"Nano Lett"},{"issue":"2","key":"4211_CR164","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1039\/D3PM00057E","volume":"1","author":"H Zou","year":"2024","unstructured":"Zou H, Boboltz A, Cheema Y, Song D, Cahn D, Duncan GA. Synthetic mucus barrier arrays as a nanoparticle formulation screening platform. RSC Pharmaceutics. 2024;1(2):218\u201326. https:\/\/doi.org\/10.1039\/D3PM00057E.","journal-title":"RSC Pharmaceutics"},{"issue":"12","key":"4211_CR165","doi-asserted-by":"publisher","first-page":"11817","DOI":"10.1021\/acsnano.3c02985","volume":"17","author":"L Xu","year":"2023","unstructured":"Xu L, Weng S, Li S, Wang K, Shen Y, Xu Y, et al. Engineering the Intestinal Lymphatic Transport of Oral Nanoparticles to Educate Macrophages for Cancer Combined Immunotherapy. ACS Nano. 2023;17(12):11817\u201337. https:\/\/doi.org\/10.1021\/acsnano.3c02985.","journal-title":"ACS Nano"},{"key":"4211_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115720","volume":"227","author":"S Kamath","year":"2025","unstructured":"Kamath S, Ariaee A, Abdelhafez A, Asif Z, Chan NSL, Collins K, et al. Microbiome-active drug delivery systems (MADDS): leveraging microbial stimuli for controlled drug release. Adv Drug Deliv Rev. 2025;227:115720. https:\/\/doi.org\/10.1016\/j.addr.2025.115720.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"4211_CR167","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1039\/D3TB02393A","volume":"12","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhuang Z, Gao R, Li R, Chen Y. \u03b2-Glycosidase sensitive oral nanoparticles for combined photothermal and chemo treatment of colorectal cancer. Journal of Materials Chemistry B. 2024;12(6):1624\u201335. https:\/\/doi.org\/10.1039\/D3TB02393A.","journal-title":"Journal of Materials Chemistry B"},{"issue":"12","key":"4211_CR168","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3109\/03639045.2015.1054833","volume":"41","author":"I Gonz\u00e1lez-Garc\u00eda","year":"2015","unstructured":"Gonz\u00e1lez-Garc\u00eda I, Mangas-Sanju\u00e1n V, Merino-Sanju\u00e1n M, Bermejo M. In vitro\u2013in vivo correlations: general concepts, methodologies and regulatory applications. Drug Dev Ind Pharm. 2015;41(12):1935\u201347. https:\/\/doi.org\/10.3109\/03639045.2015.1054833.","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"4211_CR169","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1016\/j.xphs.2024.09.005","volume":"113","author":"JD Clogston","year":"2024","unstructured":"Clogston JD, Foss W, Harris D, Oberoi H, Pan J, Pu E, et al. Current state of nanomedicine drug products: an industry perspective. J Pharm Sci. 2024;113(12):3395\u2013405. https:\/\/doi.org\/10.1016\/j.xphs.2024.09.005.","journal-title":"J Pharm Sci"},{"issue":"8","key":"4211_CR170","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.apsb.2021.03.025","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Yu Q, Chen Z, Wu W, Zhu Q, Lu Y. In vitro and in vivo correlation for lipid-based formulations: current status and future perspectives. Acta Pharm Sin B. 2021;11(8):2469\u201387. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.025.","journal-title":"Acta Pharm Sin B"},{"key":"4211_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202100147","author":"S Lin","year":"2022","unstructured":"Lin S, Wu F, Cao Z, Liu J. Advances in nanomedicines for interaction with the intestinal barrier. Adv NanoBiomed Res. 2022. https:\/\/doi.org\/10.1002\/anbr.202100147.","journal-title":"Adv NanoBiomed Res"},{"key":"4211_CR172","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","volume":"240","author":"AA Date","year":"2016","unstructured":"Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.016.","journal-title":"J Control Release"},{"key":"4211_CR173","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkag029","author":"K Qian","year":"2026","unstructured":"Qian K, Wang Y, Li R, Zhuang M, Zhao Z, Meng C, et al. Application and prospects of organoid-on-a-chip in research on the intestinal mucosal barrier. Burns Trauma. 2026. https:\/\/doi.org\/10.1093\/burnst\/tkag029.","journal-title":"Burns Trauma"},{"issue":"8","key":"4211_CR174","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1021\/acsptsci.4c00250","volume":"7","author":"O Ozbek","year":"2024","unstructured":"Ozbek O, Genc DE, Ulgen KO. Advances in physiologically based pharmacokinetic (PBPK) modeling of nanomaterials. ACS Pharmacol Transl Sci. 2024;7(8):2251\u201379. https:\/\/doi.org\/10.1021\/acsptsci.4c00250.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"9","key":"4211_CR175","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/pharmaceutics14091807","volume":"14","author":"N Rangaraj","year":"2022","unstructured":"Rangaraj N, Sampathi S, Junnuthula V, Kolimi P, Mandati P, Narala S, et al. Fast-fed variability: insights into drug delivery, molecular manifestations, and regulatory aspects. Pharmaceutics. 2022;14(9):1807. https:\/\/doi.org\/10.3390\/pharmaceutics14091807.","journal-title":"Pharmaceutics"},{"key":"4211_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107789","volume":"54","author":"A Ashkar","year":"2022","unstructured":"Ashkar A, Sosnik A, Davidovich-Pinhas M. Structured edible lipid-based particle systems for oral drug-delivery. Biotechnol Adv. 2022;54:107789. https:\/\/doi.org\/10.1016\/j.biotechadv.2021.107789.","journal-title":"Biotechnol Adv"},{"key":"4211_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121098","volume":"608","author":"TR Meola","year":"2021","unstructured":"Meola TR, Joyce P, Wignall A, Bremmell KE, Prestidge CA. Harnessing the potential of nanostructured formulations to mimic the food effect of lurasidone. Int J Pharm. 2021;608:121098. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121098.","journal-title":"Int J Pharm"},{"issue":"1","key":"4211_CR178","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11095-021-03163-0","volume":"39","author":"MT Katona","year":"2022","unstructured":"Katona MT, Kakuk M, Szab\u00f3 R, Tonka-Nagy P, Tak\u00e1cs-Nov\u00e1k K, Borb\u00e1s E. Towards a better understanding of the post-gastric behavior of enteric-coated formulations. Pharm Res. 2022;39(1):201\u201311. https:\/\/doi.org\/10.1007\/s11095-021-03163-0.","journal-title":"Pharm Res"},{"issue":"2","key":"4211_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103717","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, He C, Xia Y, Ocansey DKW, Mao F. Intestinal mucus barrier: a potential therapeutic target for IBD. Autoimmun Rev. 2025;24(2):103717. https:\/\/doi.org\/10.1016\/j.autrev.2024.103717.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"4211_CR180","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1136\/gutjnl-2018-317571","volume":"68","author":"S van der Post","year":"2019","unstructured":"van der Post S, Jabbar KS, Birchenough G, Arike L, Akhtar N, Sjovall H, et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut. 2019;68(12):2142\u201351. https:\/\/doi.org\/10.1136\/gutjnl-2018-317571.","journal-title":"Gut"},{"issue":"7","key":"4211_CR181","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.str.2017.05.003","volume":"25","author":"RM Pollet","year":"2017","unstructured":"Pollet RM, D\u2019Agostino EH, Walton WG, Xu Y, Little MS, Biernat KA, et al. An atlas of \u03b2-glucuronidases in the human intestinal microbiome. Structure. 2017;25(7):967-977.e5. https:\/\/doi.org\/10.1016\/j.str.2017.05.003.","journal-title":"Structure"},{"key":"4211_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1042606","volume":"2017","author":"T \u0160uligoj","year":"2017","unstructured":"\u0160uligoj T, Ciclitira PJ, Bo\u017ei\u010d B. Diagnostic and research aspects of small intestinal disaccharidases in coeliac disease. J Immunol Res. 2017;2017:1\u20138. https:\/\/doi.org\/10.1155\/2017\/1042606.","journal-title":"J Immunol Res"},{"key":"4211_CR183","doi-asserted-by":"publisher","unstructured":"Kowalski M, Dom\u017ca\u0142-Magrowska D, Malecka-Wojciesko E.\u00a0The Prevalence of Primary and Secondary Lactase Deficiency in Patients with Celiac Disease. 2024. https:\/\/doi.org\/10.20944\/preprints202411.1763.v1","DOI":"10.20944\/preprints202411.1763.v1"},{"issue":"supplement_1","key":"4211_CR184","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1073\/pnas.1006451107","volume":"108","author":"MEV Johansson","year":"2011","unstructured":"Johansson MEV, Larsson JMH, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host\u2013microbial interactions. Proc Natl Acad Sci U S A. 2011;108(supplement_1):4659\u201365. https:\/\/doi.org\/10.1073\/pnas.1006451107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4211_CR185","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2147\/JIR.S304101","volume":"14","author":"L Wang","year":"2021","unstructured":"Wang L, Yu M, Yang H. Recent progress in the diagnosis and precise nanocarrier-mediated therapy of inflammatory bowel disease. J Inflamm Res. 2021;14:1701\u201316. https:\/\/doi.org\/10.2147\/JIR.S304101.","journal-title":"J Inflamm Res"},{"issue":"1","key":"4211_CR186","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5009\/gnl15502","volume":"11","author":"DS Strand","year":"2017","unstructured":"Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017;11(1):27\u201337. https:\/\/doi.org\/10.5009\/gnl15502.","journal-title":"Gut Liver"},{"issue":"1","key":"4211_CR187","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","volume":"153","author":"MF Vaezi","year":"2017","unstructured":"Vaezi MF, Yang Y-X, Howden CW. Complications of Proton Pump Inhibitor Therapy. Gastroenterology. 2017;153(1):35\u201348. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.047.","journal-title":"Gastroenterology"},{"issue":"1","key":"4211_CR188","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/10717544.2017.1279238","volume":"24","author":"L Liu","year":"2017","unstructured":"Liu L, Yao W, Rao Y, Lu X, Gao J. pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms. Drug Delivery. 2017;24(1):569\u201381. https:\/\/doi.org\/10.1080\/10717544.2017.1279238.","journal-title":"Drug Delivery"},{"issue":"5","key":"4211_CR189","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1208\/s12249-021-02038-2","volume":"22","author":"V Mohylyuk","year":"2021","unstructured":"Mohylyuk V, Yerkhova A, Katynska M, Sirko V, Patel K. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison. AAPS PharmSciTech. 2021;22(5):188. https:\/\/doi.org\/10.1208\/s12249-021-02038-2.","journal-title":"AAPS PharmSciTech"},{"key":"4211_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.11119","author":"TI Hirsch","year":"2024","unstructured":"Hirsch TI, Wang SZ, Fligor SC, Quigley M, Gura KM, Puder M, et al. Fat malabsorption in short bowel syndrome: a review of pathophysiology and management. Nutr Clin Pract. 2024. https:\/\/doi.org\/10.1002\/ncp.11119.","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"4211_CR191","doi-asserted-by":"publisher","first-page":"11527","DOI":"10.1038\/s41598-022-15848-6","volume":"12","author":"EJ Onufer","year":"2022","unstructured":"Onufer EJ, Czepielewski RS, Han Y-H, Courtney CM, Sutton S, Sescleifer A, et al. Lipid absorption and overall intestinal lymphatic transport are impaired following partial small bowel resection in mice. Sci Rep. 2022;12(1):11527. https:\/\/doi.org\/10.1038\/s41598-022-15848-6.","journal-title":"Sci Rep"},{"issue":"10","key":"4211_CR192","first-page":"600","volume":"13","author":"CR Parrish","year":"2017","unstructured":"Parrish CR, DiBaise JK. Managing the Adult Patient With Short Bowel Syndrome. Gastroenterology & Hepatology. 2017;13(10):600\u20138.","journal-title":"Gastroenterology & Hepatology"},{"issue":"3","key":"4211_CR193","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/fbe2.70024","volume":"4","author":"J Renukadevi","year":"2025","unstructured":"Renukadevi J, Ranjani M, Sneha P, Hussain JS, Shakthi H. Gut-targeted nutraceutical delivery: engineering microbiome-responsive nutraceutical interfaces. Food Bioeng. 2025;4(3):248\u201361. https:\/\/doi.org\/10.1002\/fbe2.70024.","journal-title":"Food Bioeng"},{"issue":"7","key":"4211_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073464","volume":"23","author":"PT Santana","year":"2022","unstructured":"Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci. 2022;23(7):3464. https:\/\/doi.org\/10.3390\/ijms23073464.","journal-title":"Int J Mol Sci"},{"key":"4211_CR195","doi-asserted-by":"publisher","DOI":"10.5772\/27905","volume-title":"Drug development - a case study based insight into modern strategies","author":"J Vermeiren","year":"2011","unstructured":"Vermeiren J, Possemiers S, Marzorati M, de Wiele TV. The gut microbiota as target for innovative drug development: perspectives and a case study of inflammatory bowel diseases. In: Drug development - a case study based insight into modern strategies. InTech; 2011. https:\/\/doi.org\/10.5772\/27905."},{"issue":"4","key":"4211_CR196","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/molecules31040601","volume":"31","author":"J Shen","year":"2026","unstructured":"Shen J, Xu S, Zhao Q, Zhang J, Zhang H. \u03b2-Glucuronidase at the Microbiota\u2014Host Interface: Dual Regulatory Roles and Precision Modulation by Natural Products. Molecules. 2026;31(4):601. https:\/\/doi.org\/10.3390\/molecules31040601.","journal-title":"Molecules"},{"issue":"10","key":"4211_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.07.001","volume":"27","author":"S Gao","year":"2022","unstructured":"Gao S, Sun R, Singh R, Yu So S, Chan CTY, Savidge T, et al. The role of gut microbial \u03b2-glucuronidase in drug disposition and development. Drug Discov Today. 2022;27(10):103316. https:\/\/doi.org\/10.1016\/j.drudis.2022.07.001.","journal-title":"Drug Discov Today"},{"issue":"1","key":"4211_CR198","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/cimb48010063","volume":"48","author":"J Yu","year":"2026","unstructured":"Yu J, Wang P, Bei Z, Tan L, Wang J, Qin G, et al. Recent advances in oral drug delivery systems for BCS III drugs. Curr Issues Mol Biol. 2026;48(1):63. https:\/\/doi.org\/10.3390\/cimb48010063.","journal-title":"Curr Issues Mol Biol"},{"issue":"5","key":"4211_CR199","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11095-025-03849-9","volume":"42","author":"Y-H Cheng","year":"2025","unstructured":"Cheng Y-H, Thomas S, Tsang YC, Almeida S, Ashraf M, Fotaki N, et al. Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and its Regulatory Utility to Support Oral Drug Product Development and Harmonization. Pharm Res. 2025;42(5):819\u201333. https:\/\/doi.org\/10.1007\/s11095-025-03849-9.","journal-title":"Pharm Res"},{"issue":"11","key":"4211_CR200","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/pharmaceutics17111413","volume":"17","author":"Y Li","year":"2025","unstructured":"Li Y, Sun H, Zhang Z. The evolution and future directions of PBPK modeling in FDA regulatory review. Pharmaceutics. 2025;17(11):1413. https:\/\/doi.org\/10.3390\/pharmaceutics17111413.","journal-title":"Pharmaceutics"},{"key":"4211_CR201","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijbiomac.2016.12.052","volume":"96","author":"S Kumar","year":"2017","unstructured":"Kumar S, Singh SK. In silico-in vitro-in vivo studies of experimentally designed carvedilol loaded silk fibroin-casein nanoparticles using physiological based pharmacokinetic model. Int J Biol Macromol. 2017;96:403\u201320. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.12.052.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"4211_CR202","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.xphs.2018.10.037","volume":"108","author":"D Yuan","year":"2019","unstructured":"Yuan D, He H, Wu Y, Fan J, Cao Y. Physiologically-based pharmacokinetic modeling of nanoparticles. J Pharm Sci. 2019;108(1):58\u201372. https:\/\/doi.org\/10.1016\/j.xphs.2018.10.037.","journal-title":"J Pharm Sci"},{"issue":"39","key":"4211_CR203","doi-asserted-by":"publisher","first-page":"45382","DOI":"10.1021\/acsomega.5c05211","volume":"10","author":"TM da Silva","year":"2025","unstructured":"da Silva TM, Sarcinelli MA, Cunha Chaves MH, Dias A, Patricio B, Prado LD, et al. Physiologically based pharmacokinetic modeling of efavirenz nanoparticles: from animal model to human extrapolation. ACS Omega. 2025;10(39):45382\u201399. https:\/\/doi.org\/10.1021\/acsomega.5c05211.","journal-title":"ACS Omega"},{"issue":"1","key":"4211_CR204","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41467-022-35343-w","volume":"14","author":"P Bannigan","year":"2023","unstructured":"Bannigan P, Bao Z, Hickman RJ, Aldeghi M, H\u00e4se F, Aspuru-Guzik A, et al. Machine learning models to accelerate the design of polymeric long-acting injectables. Nat Commun. 2023;14(1):35. https:\/\/doi.org\/10.1038\/s41467-022-35343-w.","journal-title":"Nat Commun"},{"issue":"43","key":"4211_CR205","doi-asserted-by":"publisher","first-page":"37633","DOI":"10.1021\/acsnano.5c08608","volume":"19","author":"A Canchola","year":"2025","unstructured":"Canchola A, Li K, Chen K, Borboa-Pimentel A, Chou C, Dela Rama R, et al. Meta-analysis and machine learning prediction of protein corona composition across nanoparticle systems in biological media. ACS Nano. 2025;19(43):37633\u201350. https:\/\/doi.org\/10.1021\/acsnano.5c08608.","journal-title":"ACS Nano"},{"key":"4211_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114172","volume":"183","author":"C Chen","year":"2022","unstructured":"Chen C, Yaari Z, Apfelbaum E, Grodzinski P, Shamay Y, Heller DA. Merging data curation and machine learning to improve nanomedicines. Adv Drug Deliv Rev. 2022;183:114172. https:\/\/doi.org\/10.1016\/j.addr.2022.114172.","journal-title":"Adv Drug Deliv Rev"},{"key":"4211_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100393","volume":"10","author":"D Yanes","year":"2025","unstructured":"Yanes D, Mead H, Mann J, R\u00f6ding M, Paraskevopoulou V, Alexander C, et al. Making in vitro release and formulation data AI-ready: a foundation for streamlined nanomedicine development. Int J Pharm X. 2025;10:100393. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100393.","journal-title":"Int J Pharm X"},{"key":"4211_CR208","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3762\/bjnano.6.179","volume":"6","author":"CO Hendren","year":"2015","unstructured":"Hendren CO, Powers CM, Hoover MD, Harper SL. The Nanomaterial Data Curation Initiative: A collaborative approach to assessing, evaluating, and advancing the state of the field. Beilstein J Nanotechnol. 2015;6:1752\u201362. https:\/\/doi.org\/10.3762\/bjnano.6.179.","journal-title":"Beilstein J Nanotechnol"},{"issue":"2","key":"4211_CR209","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics8020226","volume":"8","author":"JM Donkers","year":"2023","unstructured":"Donkers JM, van der Vaart JI, van de Steeg E. Gut-on-a-chip research for drug development: implications of chip design on preclinical oral bioavailability or intestinal disease studies. Biomimetics. 2023;8(2):226. https:\/\/doi.org\/10.3390\/biomimetics8020226.","journal-title":"Biomimetics"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04211-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:08:31Z","timestamp":1790622511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04211-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":209,"alternative-id":["4211"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04211-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared that they have no competing financial interests or personal relationships that could influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}